Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by NARVnEZ, J.
Right arrow Articles by ROIG-ESCOFET, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by NARVnEZ, J.
Right arrow Articles by ROIG-ESCOFET, D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1996 British Society for Rheumatology

case-report

TERTIARY HYPERPARATHYROIDISM AFTER LONG-TERM PHOSPHATE SUPPLEMENTATION IN ADULT-ONSET HYPOPHOSPHATAEMIC OSTEOMALACIA

J. NARVnumeroEZ, J. RODRIGUEZ-MORENO, C. MORAGUES, E. CAMPOY, T. CLAVAGUERA and D. ROIG-ESCOFET

Department of Rheumatology, Hospital Principes de Esparia, Ciudad Sanitaria y Universitaria de Bellvitge, Hospitalet de Liobregat Barcelona, Spain

Correspondence to: Correspondence to: J. Narvnumeroez, Department of Rheumatology, Hospital Prindpcs de Espafia, Ciudad Sanitaria y Universitaria de Bellvitge, C/ Feixa Llarga S/N, 080907, Hospitalet de Uobregat, Barcelona, Spain.

We report the development of tertiary hyperparathyroidism in a patient with a sporadic form of adult-onset hypophosphataemic osteomalacia who had been treated with vitamin D or calcitriol and large doses of phosphate. This observation suggests that even with concomitant vitamin D or calcitriol therapy, long-term oral phosphate supplementation may lead to the development of hypercaicaemic hyperparathyroidism. Caution is recommended when relatively large doses of phosphate are used to treat hypophosphataemic osteomalacia of diverse causes.

KEY WORDS: Hypophosphataemic osteomalacia, Long-term phosphate therapy, Tertiary hyperparathyroidism


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
K. Sato, T. Obara, K. Yamazaki, M. Kanbe, K. Nakajima, A. Yamada, T. Yanagisawa, Y. Kato, T. Nishikawa, and K. Takano
Somatic Mutations of the MEN1 Gene and Microsatellite Instability in a Case of Tertiary Hyperparathyroidism Occurring during High Phosphate Therapy for Acquired, Hypophosphatemic Osteomalacia
J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5564 - 5571.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
G. P. R. Clunie, P. E. Fox, and T. C. B. Stamp
Four cases of acquired hypophosphataemic ('oncogenic') osteomalacia. Problems of diagnosis, treatment and long-term management
Rheumatology, December 1, 2000; 39(12): 1415 - 1421.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.